• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Deus Technologies debuts lung cancer detector

Article

Deus Technologies will file for premarket approval of an x-ray CAD early-stage lung cancer detection system, joining a growing list of companies that are concentrating on this disease. The product will debut at the RSNA meeting.The stand-alone system,

Deus Technologies will file for premarket approval of an x-ray CAD early-stage lung cancer detection system, joining a growing list of companies that are concentrating on this disease. The product will debut at the RSNA meeting.

The stand-alone system, called RapidScreen RS-2000, uses image processing and feature extraction technology originally employed in the analysis of satellite remote-sensing images. It analyzes regions of interest that may have features associated with solitary pulmonary nodules.

The proprietary algorithms are based on a combination of image processing, neural network, and fuzzy logic techniques developed from a database of thousands of chest films of early-stage lung cancer and cancer-free cases.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.